Original Article
Author Details :
Volume : 10, Issue : 2, Year : 2024
Article Page : 149-154
https://doi.org/10.18231/j.ijced.2024.027
Abstract
Background: Several lines of evidence show that conditions like onychomycosis and tinea pedis often tend to co-exist. While topical antifungal therapy remains the cornerstone for the management of these conditions individually, data is largely scarce on effective treatment options for coexisting cases of onychomycosis and tinea pedis.
Materials and Methods: A total of 218 healthcare professionals (dermatologists and cosmetologists) participated in the online survey on amorolfine 5% nail lacquer and 0.25% cream. Through the survey, the perspectives of these healthcare professionals (dermatologists and cosmetologists) on the management of onychomycosis tinea pedis coexistence, their views on amorolfine as a treatment option, and their patient experiences were recorded.
Results: The healthcare professionals (dermatologists and cosmetologists) reported that more than 50% of the patients had recurrent onychomycosis and tinea pedis co-infection. Most patients (72.45%) were prescribed the amorolfine cream given the lower chances of resistance, and due to the synergistic effect it provides with oral antifungals. As for the amorolfine nail lacquer, good patient compliance, lower chances of infection relapse, and better penetration properties compelled healthcare professionals to prescribe the product to most patients (82.18%). Overall, good clinical and patient experiences were noted with amorolfine products.
Conclusion: This survey-based study helped us understand the healthcare professionals' take on the management of tinea pedis and onychomycosis co-infection and it revealed that amorolfine cream and nail lacquer were effective in reducing the key symptoms of tinea pedis and onychomycosis, including lesion clearance and discoloration reduction.
Keywords: Nail infections, Antifungals, Amorolfine, Nail lacquer, Cream, Co-infection
How to cite : Bag G, Mubashir S, Sen D, Jadhwar S, Place in therapy of topical amorolfine in the management of onychomycosis and tinea pedis: A survey to understand Indian dermatologists’ perspective. IP Indian J Clin Exp Dermatol 2024;10(2):149-154
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 18-03-2024
Accepted : 04-04-2024
Viewed: 779
PDF Downloaded: 221